Phibro Animal Health (PAHC) Misses Q2 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts PAHC Hot Sheet
Join SI Premium – FREE
Phibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.33, $0.02 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $239.6 million versus the consensus estimate of $226.26 million.
GUIDANCE:
Phibro Animal Health sees FY2022 EPS of $1.30-$1.39, versus the consensus of $1.36. Phibro Animal Health sees FY2022 revenue of $930-950 million, versus the consensus of $907.5 million.
For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Marten Transport (MRTN) Misses Q3 EPS by 3c
- MaxLinear (MXL) Tops Q3 EPS by 6c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
